184 related articles for article (PubMed ID: 6199130)
1. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
Benz C; Choti M; Newcomer L; Cadman E
Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
[TBL] [Abstract][Full Text] [Related]
2. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Benz C; Cadman E
Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
5. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
8. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
Houghton JA; Tice AJ; Houghton PJ
Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
[TBL] [Abstract][Full Text] [Related]
9. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.
Danhauser LL; Heimer R; Cadman E
Cancer Chemother Pharmacol; 1985; 15(3):214-9. PubMed ID: 3876889
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.
Sawyer RC; Stolfi RL; Martin DS; Balis ME
Biochem Pharmacol; 1989 Jul; 38(14):2305-11. PubMed ID: 2751696
[TBL] [Abstract][Full Text] [Related]
11. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
Fried J; Perez AG; Doblin JM; Clarkson BD
Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
[TBL] [Abstract][Full Text] [Related]
13. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.
Kirkwood JM; Ensminger W; Rosowsky A; Papathanasopoulos N; Frei E
Cancer Res; 1980 Jan; 40(1):107-13. PubMed ID: 7349890
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-fluorouracil on methotrexate transport and cytotoxicity in HT29 colon adenocarcinoma cells.
Chen MF; Chen LT; Boyce HW
Cancer Lett; 1995 Jan; 88(2):133-40. PubMed ID: 7874685
[TBL] [Abstract][Full Text] [Related]
17. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxic effect between serine-threonine phosphatase inhibitors and 5-fluorouracil: a novel concept for modulation of cytotoxic effect.
Islam MM; Begum S; Lin L; Okamura A; Du M; Fujimura S
Cancer Chemother Pharmacol; 2002 Feb; 49(2):111-8. PubMed ID: 11862424
[TBL] [Abstract][Full Text] [Related]
19. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
20. Uridine rescue from the lethal toxicity of 5-fluorouracil in mice.
Klubes P; Cerna I; Meldon MA
Cancer Chemother Pharmacol; 1982; 8(1):17-21. PubMed ID: 6178524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
